SBOT Stock, Stellar Biotechnologies Inc. Information

Stellar Biotechnologies, Inc. OTCQB: SBOTF TSX VENTURE: KLH is the leader in sustainable manufacture of Keyhole Limpet Hemocyanin KLH , an important immune stimulating protein used in wide ranging therapeutic and diagnostic markets. KLH is both an active pharmaceutical ingredient API in many new immunotherapies targeting cancer, immune disorders, Alzheimer s and inflammatory diseases as well as a finished product for measuring immune status. Stellar Biotechnologies is unique in its proprietary methods, facilities, and KLH technology. We are committed to meeting the growing demand for commercial scale supplies of GMP grade KLH, ensuring environmentally sound KLH production, and developing KLH based active immunotherapies. Visit www.stellarbiotech.com and the KLH knowledge base www.klhsite.org.